dysgerminoma

n.  恶性胚胎瘤;无性细胞瘤

医学



双语例句

  1. Primary study on dynamic of estradiol and testosterone in deferent volume buffalo follicles The gross and microscopic appearance of an ovarian dysgerminoma is essentially the same as a seminoma of the testis in a male.
    水牛卵泡液中雌二醇和睾酮水平变化的初步研究卵巢的无性细胞瘤肉眼和显微镜下表现基本上与男性睾丸的精原细胞瘤一致。
  2. The gross and microscopic appearance of an ovarian dysgerminoma is essentially the same as a seminoma of the testis in a male.
    卵巢的无性细胞瘤肉眼和显微镜下表现基本上与男性睾丸的精原细胞瘤一致。
  3. A case of pediatric ovarian dysgerminoma associated with high serum levels and positive immunohistochemical staining of neuron-specific enolase
    1例儿童卵巢无性细胞瘤伴高血清肿瘤标记物水平和神经细胞特异性烯醇化酶的免疫组织化学着色反应阳性
  4. Dysgerminoma of Ovary: Clinical Analysis of 30 Cases
    卵巢无性细胞瘤30例临床分析
  5. The expression percentage of P-selectin in immature teratoma, dysgerminoma and Yolk sac tumor is 100% ( 17/ 17), 84.2% ( 16/ 19) and 84.6% ( 11/ 13).
    其中,P&选择素在未成熟畸胎瘤、无性细胞瘤、卵黄囊瘤中的阳性表达率分别是100%(17/17)、84.2%(16/19)和84.6%(11/13);
  6. Objective: To evaluate the expressions of placental alkaline phosphatase ( PLAP), neuronspecific enolase ( NSE), prolactin ( PRL) and Wilm ′ s tumor ( WT1) in ovarian dysgerminoma and their clinicopathological significance.
    目的:评价胎盘碱性磷酸酶(PLAP),神经元特异性烯醇化酶(NSE)、催乳素(PRL)和肾母细胞瘤(WT1)基因蛋白在卵巢无性细胞瘤中的表达及其临床病理意义。
  7. Conclusion The prognosis of ovarian dysgerminoma is closely related to clinical staging and treatment modality.
    结论卵巢无性细胞瘤的预后与临床分期、治疗方法密切相关。
  8. Conclusions The differential level of dysgerminoma and embryonal carcinoma approximates the stages of gonocyte and blastocyst.
    结论卵巢生殖细胞肿瘤中无性细胞瘤和胚胎性癌分化水平最接近于生殖母细胞至胚泡阶段。
  9. CD117 and CD30 immunostains, when used in combination, represent valuable tools for distinguishing embryonal carcinoma and seminoma, dysgerminoma, germinoma.
    联合应用OCT4、CD117和CD30对于诊断和鉴别诊断精原细胞瘤、生殖细胞瘤、无性细胞瘤和胚胎性癌具有较高的应用价值。
  10. Background& Objective: Ovarian dysgerminoma is an uncommen ovarian malignancy. Its clinical features are special and there are many factors influencing the prognosis.
    背景与目的:卵巢无性细胞瘤是一少见的卵巢恶性肿瘤,其临床表现特异,影响预后的因素较多。
  11. The aim of this study is to investigate the clinical features and factors related to prognosis of ovarian dysgerminoma.
    本研究的目的是探讨卵巢单纯性无性细胞瘤的临床行为特点和影响其预后的因素。
  12. Methods 40 cases with pure ovarian dysgerminoma were performed operation and postoperative adjuvant chemotherapy and/ or radiotherapy. In long-term follow-up, clinical effects were observed.
    方法对40例单纯无性细胞瘤进行手术治疗及术后辅助放/化疗,并长期随访,观察治疗效果。
  13. Follow-up and Analysis on 10-years Survival Rate of Ovary Dysgerminoma
    卵巢无性细胞瘤10年生存率随访结果及分析
  14. Analysis of the Treatment for Ovaria Dysgerminoma and Discussion for Remaining Fertility
    卵巢无性细胞瘤的治疗分析与保存生育能力的探讨
  15. Clinical characteristics and prognosis of ovarian dysgerminoma
    卵巢无性细胞瘤的临床特点及预后影响因素
  16. Objective To understand the clinical and pathological characteristics, and prognosis of ovarian dysgerminoma were well acquired for further improvement in medical management.
    目的研究卵巢无性细胞瘤的临床与病理特征以及预后情况。
  17. PLAP and NSE can be considered as important markers of dysgerminoma tissues, and the tumor tissues are the main resources of serum NSE and PLAP.
    PLAP和NSE可看作是无性细胞瘤重要的组织标志物,肿瘤组织是血清PLAP和NSE的主要来源。